Modulating Ca²⁺ release by the IP₃R/Ca²⁺ channel as a potential therapeutic treatment for neurological diseases

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.5, 2013-09, pp. : 629-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of Na⁺ and Ca²⁺ channel blockers in pain management

By Sabido-David Cibele Faravelli Laura Salvati Patricia

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1249-1261

Informa Healthcare

Access to resources Recommend Favorite

Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases

Current Medicinal Chemistry, Vol. 16, Iss. 25, 2009-09 ,pp. : 3294-3321

Bentham Science Publishers

Access to resources Recommend Favorite

Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca2+ Release Channel: Case Study of Dantrolene

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-01 ,pp. : 1062-1072

Bentham Science Publishers

Access to resources Recommend Favorite

Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3195-3211

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of the Ca 2+ release channel of sarcoplasmic reticulum by amiloride analogs

By Ponte C.G. Estrela R.C.E. Suarez-Kurtz G.

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 11-20

Elsevier

Access to resources Recommend Favorite